European Archives - Page 3 of 1596 - European Medical Journal

Mimicking Breastmilk Lipids

This symposium review examines whether mimicking breastmilk lipid globule architecture in infant formula may influence health outcomes in…

Psoriasis in High-Impact Areas and QoL

When patients are living with psoriasis in high-impact body areas, defining disease severity by objective measures of body surface extent…

Hydrophilic Catheters: PVP Concerns

Intermittent catheterisation (IC) is practised by patients with a variety of conditions that can affect bladder function, including spinal…

Optimising Diagnosis and Management of Obstructive Müllerian Anomalies

Müllerian anomalies are a group of anomalies of the reproductive tract resulting from incomplete or atypical development of the Müllerian…

Apparent Drug-Induced Anaphylaxis from Semen

Hypersensitivity reactions associated with intimate sexual activity are probably underdiagnosed and frequently go undiagnosed. Reported…

Inflammatory Biomarkers in Individuals with SCD in Kano

Sickle cell disease (SCD) is a genetic disease that is due to single nucleotide polymorphism of the β-haemoglobin gene in the first exon…

Intratesticular Platelet-Rich Plasma in Severe Male Factor Infertility and Non-obstructive Azoospermia

Male factor infertility contributes to approximately half of all infertility cases, affecting one in six couples worldwide.1 Azoospermia…

Vomiting Induced Cartoid Artery Dissection Caused by Hypermobile Ehlers-Danlos Syndrome

Carotid artery dissection (CAD) can arise from traumatic, spontaneous, and iatrogenic causes. Spontaneous CAD is generally rare, but a…

Person holding model stormach

New Microscope Offers Hope for People with Inflammatory Bowel Disease

A new super-resolution microscope could help scientists better understand IBD and identify potential targets for treatment.

Closeup of the Novo Nordisk sign outside its office in Fremont, California. Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd

Novo Nordisk rebrands to the single name 'Novo'

The change to ‘Novo’ follows two years of share-price declines, a change of leadership and falling market share.